{"name":"Teijin America, Inc.","slug":"teijin-america-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxNdHlrMGk3cUpOQVdncUxTaTRDZnZpdWNLaDBOd2hWNmxMWHp5X1Bjc01fSmRueUc5NjIxUFFVVnBabVE0Wm1uY1JCcWxFWHlvbk1MM1ZRT1kweTQ4RHdia1J1bG4xVDBpZ2lRYXJydXdvS0NqNUFXc2xoUjJDUFdFNGhLOXpsUGNZaHhSY1l3ZnAxQ1JhZDl5WTZuemx0WUJBQzJwM3hXRUt6MzVYU3l2YXR5c3c4dmstSmhNZnkxaDhGZWpUenJyNVFtZE5hWEJpdHhDSHlfUnp3T3VMemthMV9palFuQmtmNFlDR2xRNldaRlhWeUNkeGk5UVI5eEt1WEo2dlJYcHJ4TVhMa2VDMWFaTmR6NmZmRjFsRzIyRjg2b1RPQlNXOVBPSGVGTFNlNl9SblloaThwcnFTanp5UFA5X3JDN3FCWURaSks5N21iUQ?oc=5","date":"2026-01-23","type":"regulatory","source":"Barchart.com","summary":"Rheumatoid Arthritis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Eli Lilly and Company, Philogen, I-Mab Biopharma, Teijin Pharma, Revolo - ","headline":"Rheumatoid Arthritis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOMUd0VjE4MWxHX0ZoaGRrUVRzejVIQWFHTVhOVFoyZ0hGdmNQT25QYTZienJ5WWIwcUxUdTgzVnRGVmdiVzN0MzBmaTlaWmQ4UER5U0ZxdkNiTWxHMy1TLUhaQ3NvdjJBRUREWkVOMUMxdUdRNkk2WllGVmZFM1p0RVlfM05YcXU5MHFlMA?oc=5","date":"2025-12-03","type":"pipeline","source":"Plastics News","summary":"Asahi Kasei reshapes portfolio with joint venture and battery separator divestiture - Plastics News","headline":"Asahi Kasei reshapes portfolio with joint venture and battery separator divestiture","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOcV9FY0tfUVROYWZmbktnVkZMcmxoLUdqOHRYMlNtQm9kdy1OMk1KY2dJSmIxRVdaU2NHa3JMdzlOaHdnTmY1eEhvbGZzNjd0RTd1MzFvRElLdkJmZFg5SWhpVC1Ka0M4SUNfV01HY0JrZmZab05WR2NLWjRJcDQ2Q3lvc2xWdXVfdHczc25jYy1nSHBGNU5IZTJJSXpPOERzcW1kQlR5YWJyVUVvaUNVeXVpWUV6eWlEeE5JTzJrOUZvdmZGdFBsUmVwLWRXcl92b2ZzNTQ1WEc0SlU?oc=5","date":"2025-12-01","type":"pipeline","source":"Business Wire","summary":"Asahi Kasei Advance and Teijin Frontier to Integrate Businesses for Sustainable Growth - Business Wire","headline":"Asahi Kasei Advance and Teijin Frontier to Integrate Businesses for Sustainable Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOVjVBTmxuVlZycC1yaWRQTmxjSkthNy11MlVTMVdIbkE2VTdEM0ZURFUyR3Z6SDVEdGdvMVl4Qng3OWNxaWpZcTRCLU0tdExnNVp0LVctSi1ZaE1EbUdxNnZlRTFzVnVUY1c4OXNpSFhiT0xNcWhIVUdCUGswS3BUSWFEbTgxSDJOel9zUE5ua3kxV3dD?oc=5","date":"2025-10-16","type":"regulatory","source":"lupin.com","summary":"Lupin Receives Approval from U.S. FDA for Febuxostat Tablets - lupin.com","headline":"Lupin Receives Approval from U.S. FDA for Febuxostat Tablets","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPUHgtem5ibTFJeXlaekh0aWIyaWxWa2dPdUUtUVpUeXRGNXJjaVBqMlpOUkFsbDZlTDI0WUZJY1ZMODNPX0FrWlB2ZWtyVkhnOFgyc2FkWGpScHJuUFNTQ1lrVWc0aEU4b1hRcFJIWWhBYzZROTZTNEFVUWdYUGkwNkkySVNGeXZYeV9BdzlzaXZ0WW9SbkgtUzNUQ0dCUE5YRzhabm9tUjZWd2dTbW9UR3psbTBkakxEbEZVZW11aHlKVHhmQXJIMGtvRQ?oc=5","date":"2025-07-24","type":"trial","source":"Sleep Review","summary":"New Data Suggests Best Orexin Receptor Agonists Are Still to Come - Sleep Review","headline":"New Data Suggests Best Orexin Receptor Agonists Are Still to Come","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1ZY2lrYWVWc2g5b290X3IzYk1HUWpDQWVkT0kxUGE5eVFNMTY5bHRReVc4WnE0TVZ1cHZiU3lFR29lei1kM29iNkk1c056SkExMDlXTmlaWGFWZmQzU0NqUXNHbzJYRkVTRnZLd2RJVmczRWZSbEVJNTk4TQ?oc=5","date":"2025-05-12","type":"earnings","source":"Precedence Research","summary":"Botulinum Toxin Market Revenue to Attain USD 19.68 Bn by 2033 - Precedence Research","headline":"Botulinum Toxin Market Revenue to Attain USD 19.68 Bn by 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE45c0c0Wi1mTlJKQVdVR0V3akRuZjl4U0JiUzZsRG9UTHd2b1hhWUNxT3IyeFZ2MVVNUXh4eVVfVlQ2U1dHdTdHUl9vdC1faldMb0JuMFdjTVNLME9D?oc=5","date":"2024-11-06","type":"pipeline","source":"EurekAlert!","summary":"Chinese herbal medicine’s potential in preventing dementia - EurekAlert!","headline":"Chinese herbal medicine’s potential in preventing dementia - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQQjBYYy0wV3JNTmg3OU5tYVQtcXVoVE5ULTNZQkdVeHF0bzNkWDJjNkY5Sk5MR1JIbEpzT2VoRWhrVGZnV3JhbGlXZE1KT1JJYkMzUzc1cnNVNHBZdzVIMWVsdDFESHZoS01GeS03bGdjcmMwb21jYUFtSnVMcF9FdnQxenBuYzRwUU5WaG9lWDYyQlozT3ltR3NZMnV0eEJBSUd2WE5sLXozM0ZGdkpiUkU2akYya251UEZkZnVaTTMwclo0S1haY0tR?oc=5","date":"2021-09-22","type":"pipeline","source":"PR Newswire","summary":"Five Strong Organizations Rebranded to form Teijin Automotive Technologies - PR Newswire","headline":"Five Strong Organizations Rebranded to form Teijin Automotive Technologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNSThuVUpjZnZNazhmZ1BvT3IxSkVlUmwxcUVFTVNsNVZrRTkwOWk2aUJIYjVlNkp6QTdxU2tDTkRDdWNOTkNGZXBDM2xzOUhDclBLekZuT18wREpRNmZobENfeWV3cExSeUp4LU9yMFdCMlZjSjllNU13cnJVSmVORkRndTJVdjJqRkNaOF82ZEtlbVZjR2hDcTdJZndBODlrY3ZBbGp6eGd1b3pvbVNfZVhnQnMxZnM3b1VwREpnb2ROUEEyN1JzZFdmRGsxYlRXd2c?oc=5","date":"2021-02-26","type":"pipeline","source":"Reuters","summary":"Japan's Takeda sells four diabetes products to Teijin Pharma for $1.25 bln - Reuters","headline":"Japan's Takeda sells four diabetes products to Teijin Pharma for $1.25 bln","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNXzB2LTVKNDB4M2JwX3hhclAzMDJxNFRFWEhmRktsRmtRTDVOUnVQd3BzaGFCOEt4LUppZm9SeFRJYWdSSk5CbGh0RGJ4clByZkpTSXdRRDNGSEJRVExhMWZ6LVE5ZGpWdU96WDd3N0hwX3NiYVZIU0c3N0RvZ3NVY3dUUVV3Q0NGRnp5Y1FMVU5ITmFBYkxGQzI4bHdndW1Zd2FUdFpsSk9aYWpNNU9rd3ZEU3NpMWc?oc=5","date":"2019-10-17","type":"deal","source":"PR Newswire","summary":"Teijin and NeuroSigma Enter into Exclusive License Agreement - PR Newswire","headline":"Teijin and NeuroSigma Enter into Exclusive License Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOZ1dsNWo2ZkxVWXZNdWtUTS0yNzFwRnRHMVExMk9FdWF3ZnhiSTdMWmRYRF9yM0JIVi1admZVa0YtbEs5cldFYlRNbFl6Q205V2tNcDRpZnUwZ2NzOXNSbTNtbVk5VlJ4alI2ZGVnUUl4UFBBQWlnbzZWdEJQYXFqb1NjMVY2VnA1RFlEcWVhWG9NeVdwY1dQa3ZuOA?oc=5","date":"2019-04-04","type":"regulatory","source":"BioSpectrum Asia","summary":"Japan approves first drug for ADA deficiency - BioSpectrum Asia","headline":"Japan approves first drug for ADA deficiency","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQM3dLalNGdWRjejJ0NUY0NkcweUczZWF0VzZ1bzVHcTJmVnR0Uy1Db0RLMlZaOV9BYy1lVzdEODdQNW56VWVaY2dsbXRRXy1XWkZWU3NnemxfbDJNdGhwUDdJY3JIb05YaFpaQXd2T013Vlp1MzRnRXhDa1JUSjNZa2pqbjlDRFZKUjJ1U1pNdWMtMWI4aGdOa25WSm8zWkVuRG84TThLc1Y0cHBqbXc?oc=5","date":"2017-05-25","type":"trial","source":"Fierce Biotech","summary":"Months after trial setbacks, Merck licenses Teijin Alzheimer’s candidate - Fierce Biotech","headline":"Months after trial setbacks, Merck licenses Teijin Alzheimer’s candidate","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}